Yallaferon in Chinese Population
Yallaferon in Chinese Population
The purpose of this study is to evaluate the efficacy of Yallaferon in Chinese population
 with HPV-16 and/or HPV-18.
Inclusion Criteria:

 -  Age 25 to 65 years of age the sex life of female patients;

 -  High-risk HPV 16 and/or 18 positive

 -  Agree to sign ICF

 Exclusion Criteria:

 -  Cervical intraepithelial neoplasia (CIN);

 -  Combined with a severe fungal, trichomonas vaginitis;

 -  Severe primary diseases associated with cardiovascular, liver, kidney and
 hematopoietic system;

 -  Allergies or allergy to the drug known ingredients.

 -  Within 30 days to accept other clinical trials of drugs or are participating in
 clinical trials;

 -  Pregnant and lactating women and to be pregnant women;

 -  The researchers do not consider it appropriate clinical trials.